Omegacin


Indications and Reactions:

Role Indications Reactions
Secondary
Pneumonia 17.0%
Pyrexia 12.7%
Hypertension 7.3%
Prophylaxis 7.3%
Drug Use For Unknown Indication 6.1%
Interstitial Lung Disease 6.1%
Immunosuppressant Drug Therapy 4.8%
Allogenic Bone Marrow Transplantation Therapy 3.6%
Colorectal Cancer 3.6%
Immunosuppression 3.6%
Inflammation 3.6%
Musculoskeletal Pain 3.6%
Sedation 3.6%
Gastric Ulcer 3.0%
Hyperlipidaemia 2.4%
Pneumonia Aspiration 2.4%
Product Used For Unknown Indication 2.4%
Respiratory Tract Infection 2.4%
Stem Cell Transplant 2.4%
Antidepressant Therapy 1.8%
Toxic Epidermal Necrolysis 10.0%
White Blood Cell Count Decreased 10.0%
Erythema Multiforme 6.7%
Hepatic Function Abnormal 6.7%
Hypoalbuminaemia 6.7%
Liver Disorder 6.7%
Renal Impairment 6.7%
Sepsis 6.7%
Atrioventricular Block 3.3%
Blood Bilirubin Increased 3.3%
Blood Creatine Increased 3.3%
Blood Magnesium Decreased 3.3%
Diarrhoea 3.3%
Eosinophilic Pneumonia 3.3%
Generalised Erythema 3.3%
Inflammation 3.3%
Interstitial Lung Disease 3.3%
Nausea 3.3%
Pancytopenia 3.3%
Pneumonia Fungal 3.3%
Concomitant
Prophylaxis 11.6%
Drug Use For Unknown Indication 11.6%
Product Used For Unknown Indication 10.5%
Infection Prophylaxis 9.2%
Acute Lymphocytic Leukaemia 7.9%
Pneumonia 5.5%
Multiple Myeloma 5.2%
Fluid Replacement 4.6%
Sedation 4.1%
Rheumatoid Arthritis 4.1%
Infection 3.8%
Sepsis 3.6%
Neutropenia 3.2%
Prophylaxis Against Graft Versus Host Disease 2.9%
Pyrexia 2.8%
Ureteral Stent Insertion 2.0%
Ureteral Stent Removal 2.0%
Hepatic Function Abnormal 1.9%
Myelodysplastic Syndrome 1.8%
Liver Disorder 1.7%
White Blood Cell Count Decreased 11.9%
Sepsis 9.5%
Pneumatosis Intestinalis 8.7%
Renal Impairment 8.7%
Respiratory Failure 7.1%
Septic Shock 7.1%
Thrombocytopenia 5.6%
Pneumonia 4.8%
Febrile Neutropenia 4.0%
Hypernatraemia 4.0%
Pleural Effusion 4.0%
Cardiac Failure 3.2%
Death 3.2%
Hypoglycaemia 3.2%
Pyrexia 3.2%
Hepatic Function Abnormal 2.4%
Hypokalaemia 2.4%
Pulmonary Alveolar Haemorrhage 2.4%
Rash 2.4%
Tremor 2.4%

Drug Data